Investigación / Grupos de investigación

Publicaciones (60)

  • Giner, F; Lopez-Guerrero, JA; Machado, I; Rubio-Martinez, LA; Espino, M; Navarro, S; Agra-Pujol, C; Ferrandez, A; Llombart-Bosch, A.

    Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases

    VIRCHOWS ARCHIV. 2023; 482(2): 407-417 Nº de citas: 3 [doi:10.1007/s00428-022-03453-x]

  • Galera, M; Alvarez, R; Arregui, M; Paniagua, M; Alvarez, A; Crisostomo, RAG; Díazgranados, A; Gutiérrez, N; Calles, A; Agra, C.

    A Clear Cell Sarcoma Case: A Diagnostic and Treatment Challenge, with a Promising Response to Trabectedin

    Case Reports in Oncology. 2023; 16(1): 1542-1550 Nº de citas: 1 [doi:10.1159/000534935]

  • Baptista, MJ; Tapia, G; Munoz-Marmol, AM; Muncunill, J; Garcia, O; Montoto, S; Gribben, JG; Calaminici, M; Martinez, A; Veloza, L; Martinez-Trillos, A; Aldamiz, T; Menarguez, J; Terol, MJ; Ferrandez, A; Alcoceba, M; Briones, J; Gonzalez-Barca, E; Climent, F; Muntanola, A; Moraleda, JM; Provencio, M; Abrisqueta, P; Abella, E; Colomo, L; Garcia-Ballesteros, C; Garcia-Caro, M; Sancho, JM; Ribera, JM; Mate, JL; Navarro, JT.

    Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

    HISTOPATHOLOGY. 2022; 81(6): 826-840 Nº de citas: 10 [doi:10.1111/his.14798]

  • Martinez-Laperche, C; Sanz-Villanueva, L; Crespo, FJD; Muniz, P; Rojas, RM; Carbonell, D; Chicano, M; Suarez-Gonzalez, J; Menarguez, J; Kwon, M; Martin, JLD; Buno, I; Oreiro, MB.

    EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

    BMC CANCER. 2022; 22(1): Nº de citas: 10 [doi:10.1186/s12885-022-10070-z]

  • Valera-Mele, M; Alles, JVD; Juretschke, FR; Vendrell, ES; Poveda, JMH; Afonso, AM; Hernando, VC; Leal, RG.

    Primary central nervous system angiosarcoma with recurrent acute subdural hematoma

    NEUROCIRUGIA. 2022; 33(4): 199-203 Nº de citas: 1 [doi:10.1016/j.neucir.2021.02.002]

  • Martinez, MA; Cuelar, IN; Urmeneta, AS; Serrano, FA; Cuelar, CN.

    Large cell neuroendocrine carcinoma on the floor of the mouth: a rare entity in an unusual location

    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY. 2022; 51(6): 742-745 Nº de citas: 1 [doi:10.1016/j.ijom.2021.08.021]

  • Cortese, S; Peligros, MI; Sola, E; Garcia-Alfonso, P; Tellado, JM.

    Indocyanine green clearance test as a predictor of chemotherapy liver toxicity and post-operative complications in patients with colorectal liver metastases

    CIRUGIA Y CIRUJANOS. 2022; 90(3): 310-318 Nº de citas: 1 [doi:10.24875/CIRU.21000313]

  • Rodriguez-Lomba, E; Garcia-Piqueras, P; Lozano-Masdemont, B; Nieto-Benito, LM; de la Torre, EH; Parra-Blanco, V; Suarez-Fernandez, R; Lazaro-Ochaita, P; Aviles-Izquierdo, JA.

    'Rainbow pattern': a dermoscopic sign of invasive melanoma

    CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2022; 47(3): 529-533 Nº de citas: 7 [doi:10.1111/ced.14950]

  • Gutiérrez-Seijo A; García-Martínez E; Barrio-Alonso C; Parra-Blanco V; Avilés-Izquierdo JA; Sánchez-Mateos P; Samaniego R.

    Activin A Sustains the Metastatic Phenotype of Tumor-Associated Macrophages and Is a Prognostic Marker in Human Cutaneous Melanoma

    JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2022; 142(3 PT A): 653 Nº de citas: 6 [doi:10.1016/j.jid.2021.07.179]

  • Ruiz-Minaya, M; Mendizabal-Vicente, E; Vasquez-Jimenez, W; Perez-Burrel, L; Aracil-Moreno, I; Agra-Pujol, C; Bernal-Claverol, M; Martinez-Bernal, BL; Munoz-Fernandez, M; Morote-Gonzalez, M; Ortega, MA; Lizarraga-Bonelli, S; De Leon-Luis, JA.

    Retrospective Analysis of Patients with Gynaecological Uterine Sarcomas in a Tertiary Hospital

    Journal Of Personalized Medicine. 2022; 12(2): Nº de citas: 1 [doi:10.3390/jpm12020222]

  • de Villambrosia, SG; Bastos, M; Palanca, JM; Cruz, JG; Navarro, JT; Tapia, G; Alonso, SA; Martin, A; Blanco, O; Abrisqueta, P; Castellvi, J; Garcia-Noblejas, A; Arranz, R; Adrados, M; Lopez, A; Montes-Moreno, S; Grp Espanol Iinfomas Trasplante GE.

    BCL2 translocation in high grade B cell lymphoma (NOS, DH/TH) is associated with reduced progression free survival

    LEUKEMIA & LYMPHOMA. 2022; 63(1): 101-108 Nº de citas: 5 [doi:10.1080/10428194.2021.1975189]

  • Martin-Rojas, RM; Gomez-Centurion, I; Bailen, R; Bastos, M; Diaz-Crespo, F; Carbonell, D; Correa-Rocha, R; Pion, M; Munoz, C; Sancho, M; Fernandez, IG; Oarbeascoa, G; Perez-Corral, A; Martinez-Laperche, C; Anguita, J; Buno, I; Menarguez, J; Diez-Martin, JL; Kwon, M.

    Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

    Clinical Case Reports. 2022; 10(1): Nº de citas: 27 [doi:10.1002/ccr3.5209]

  • Alvarez-Uria, A; Escribano, P; Parra-Blanco, V; Cano-Lira, JF; Stchigel, AM; Oarbeascoa, G; Munoz, P; Guinea, J.

    First Report of an Invasive Infection by Cephalotrichum gorgonifer in a Neutropenic Patient with Hematological Malignancy under Chemotherapy

    Journal of Fungi. 2021; 7(12): Nº de citas: 1 [doi:10.3390/jof7121089]

  • Bastos-Oreiro, M; Suarez-Gonzalez, J; Andres-Zayas, C; Carrion, NC; Moreno, S; Carbonell, D; Chicano, M; Muniz, P; Sanz, L; Diaz-Crespo, FJ; Menarguez, J; Diez-Martin, JL; Buno, I; Martinez-Laperche, C.

    Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin's lymphoma

    Scientific Reports. 2021; 11(1): 22815-22815 Nº de citas: 8 [doi:10.1038/s41598-021-02362-4]

  • Nieto-Benito, LM; Bergon-Sendin, M; Pulido-Perez, A; Rosell-Diaz, AM; Parra-Blanco, V; Suarez-Fernandez, R.

    Defining dipeptidyl peptidase-4 inhibitors-related bullous pemphigoid: A single-centre retrospective study

    EXPERIMENTAL DERMATOLOGY. 2021; 30(9): 1345-1351 Nº de citas: 6 [doi:10.1111/exd.14387]

  • Frontzek, F; Staiger, AM; Zapukhlyak, M; Xu, WD; Bonzheim, I; Borgmann, V; Sander, P; Baptista, MJ; Heming, JN; Berning, P; Wullenkord, R; Erdmann, T; Lutz, M; Veratti, P; Ehrenfeld, S; Wienand, K; Horn, H; Goodlad, JR; Wilson, MR; Anagnostopoulos, I; Lamping, M; Gonzalez-Barca, E; Climent, F; Salar, A; Castellvi, J; Abrisqueta, P; Menarguez, J; Aldamiz, T; Richter, J; Klapper, W; Tzankov, A; Dirnhofer, S; Rosenwald, A; Mate, JL; Tapia, G; Lenz, P; Miething, C; Hartmann, W; Chapuy, B; Fend, F; Ott, G; Navarro, JT; Grau, M; Lenz, G.

    Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma

    Nature Communications. 2021; 12(1): 5183-5183 Nº de citas: 33 [doi:10.1038/s41467-021-25405-w]

  • Gutierrez-Seijo, A; Garcia-Martinez, E; Barrio-Alonso, C; Pareja-Malagon, M; Acosta-Ocampo, A; Fernandez-Santos, ME; Puig-Kroger, A; Parra-Blanco, V; Mercader, E; Marquez-Rodas, I; Aviles-Izquierdo, JA; Samaniego, R; Sanchez-Mateos, P.

    CCL20/TNF/VEGFA Cytokine Secretory Phenotype of Tumor-Associated Macrophages Is a Negative Prognostic Factor in Cutaneous Melanoma

    Cancers. 2021; 13(16): Nº de citas: 8 [doi:10.3390/cancers13163943]

  • Fernandez-Acenero, MJ; Barderas, R; Garcia, AP; Martinez-Useros, J; Diez-Valladares, L; Perez-Aguirre; Medina, LO; Esteban, SD; Garcia-Botella, S; del Arco, CD; Galindo, C.

    Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma

    ANNALS OF DIAGNOSTIC PATHOLOGY. 2021; 53: 151742-151742 Nº de citas: 6 [doi:10.1016/j.anndiagpath.2021.151742]